Arturo Casadevall

InstitutionDepartment of Molecular Microbiology and Immunology
AddressBaltimore
Maryland
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 14 Covid-19 publications, with a maximum of 3 publications in July 2020 and Spetember 2020
    All Publications
    Bar chart showing 481 publications over 19 distinct years, with a maximum of 36 publications in 2009
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Klein SL, Pekosz A, Park HS, Ursin RL, Shapiro JR, Benner SE, Littlefield K, Kumar S, Naik HM, Betenbaugh MJ, Shrestha R, Wu AA, Hughes RM, Burgess I, Caturegli P, Laeyendecker O, Quinn TC, Sullivan D, Shoham S, Redd AD, Bloch EM, Casadevall A, Tobian AA. Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population. J Clin Invest. 2020 Nov 02; 130(11):6141-6150. PMID: 32764200.
      Citations: 10     Fields:    
    2. Casadevall A, Joyner MJ, Pirofski LA. SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy. J Clin Invest. 2020 10 01; 130(10):5112-5114. PMID: 32634126.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    3. Liu STH, Lin HM, Baine I, Wajnberg A, Gumprecht JP, Rahman F, Rodriguez D, Tandon P, Bassily-Marcus A, Bander J, Sanky C, Dupper A, Zheng A, Nguyen FT, Amanat F, Stadlbauer D, Altman DR, Chen BK, Krammer F, Mendu DR, Firpo-Betancourt A, Levin MA, Bagiella E, Casadevall A, Cordon-Cardo C, Jhang JS, Arinsburg SA, Reich DL, Aberg JA, Bouvier NM. Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study. Nat Med. 2020 Sep 15. PMID: 32934372.
      Citations: 8     Fields:    
    4. Benner SE, Patel EU, Laeyendecker O, Pekosz A, Littlefield K, Eby Y, Fernandez RE, Miller J, Kirby CS, Keruly M, Klock E, Baker OR, Schmidt HA, Shrestha R, Burgess I, Bonny TS, Clarke W, Caturegli P, Sullivan D, Shoham S, Quinn TC, Bloch EM, Casadevall A, Tobian AAR, Redd AD. SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors. J Infect Dis. 2020 Sep 10. PMID: 32910175.
      Citations:    Fields:    
    5. Citations: 39     Fields:    Translation:HumansCellsPHPublic Health
    6. Imperiale MJ, Casadevall A. Rethinking Gain-of-Function Experiments in the Context of the COVID-19 Pandemic. mBio. 2020 08 07; 11(4). PMID: 32769091.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    7. Casadevall A, Joyner MJ, Pirofski LA. A Randomized Trial of Convalescent Plasma for COVID-19-Potentially Hopeful Signals. JAMA. 2020 08 04; 324(5):455-457. PMID: 32492105.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    8. Citations: 12     Fields:    Translation:HumansPHPublic Health
    9. Bergman A, Sella Y, Agre P, Casadevall A. Oscillations in U.S. COVID-19 Incidence and Mortality Data Reflect Diagnostic and Reporting Factors. mSystems. 2020 Jul 14; 5(4). PMID: 32665331.
      Citations:    
    10. Pirofski LA, Casadevall A. Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework. mBio. 2020 07 02; 11(4). PMID: 32616514.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    11. Bloch EM, Shoham S, Casadevall A, Sachais BS, Shaz B, Winters JL, van Buskirk C, Grossman BJ, Joyner M, Henderson JP, Pekosz A, Lau B, Wesolowski A, Katz L, Shan H, Auwaerter PG, Thomas D, Sullivan DJ, Paneth N, Gehrie E, Spitalnik S, Hod EA, Pollack L, Nicholson WT, Pirofski LA, Bailey JA, Tobian AA. Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Invest. 2020 06 01; 130(6):2757-2765. PMID: 32254064.
      Citations: 101     Fields:    Translation:HumansCellsPHPublic Health
    12. Ahima RS, Jackson S, Casadevall A, Semenza GL, Tomaselli G, Collins KL, Lieberman AP, Martin DM, Reddy P. Changing the editorial process at JCI and JCI Insight in response to the COVID-19 pandemic. J Clin Invest. 2020 05 01; 130(5):2147. PMID: 32202513.
      Citations: 1     Fields:    Translation:PHPublic Health
    13. Casadevall A, Pirofski LA. The convalescent sera option for containing COVID-19. J Clin Invest. 2020 04 01; 130(4):1545-1548. PMID: 32167489.
      Citations: 132     Fields:    Translation:HumansCellsPHPublic Health
    14. Imperiale MJ, Casadevall A. Vagueness and costs of the pause on gain-of-function (GOF) experiments on pathogens with pandemic potential, including influenza virus. mBio. 2014 Dec 12; 5(6). PMID: 25505121.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    15. Casadevall A, Shenk T. mBio addresses the pause in gain-of-function (GOF) experiments involving pathogens with pandemic potential (PPP). mBio. 2014 Dec 12; 5(6). PMID: 25505126.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    Casadevall's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (1150)
    Explore
    _
    Co-Authors (258)
    Explore
    _
    Similar People (60)
    Explore
    _
    Physical Neighbors
    _